Appropriate patient and device selection crucial for clinical benefit following renal stenting.
Zeller
Thomas
T
D017130:Angioplasty / Q000009:adverse effects / Q000295:instrumentation*; D015415:Biomarkers / Q000097:blood; D003404:Creatinine / Q000097:blood; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D005374:Filtration / Q000295:instrumentation; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012078:Renal Artery Obstruction / Q000188:drug therapy / Q000628:therapy*; D018570:Risk Assessment; D012307:Risk Factors; D015607:Stents; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
D015415:Biomarkers; D010975:Platelet Aggregation Inhibitors; D003404:Creatinine